Compounds > cyclosporine

cyclosporine and Hyperlipoproteinemias

cyclosporine has been researched along with Hyperlipoproteinemias in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aliabadi, HM; Brocks, DR; Lavasanifar, A; Mahdipoor, P; Spencer, TJ1
Bard, JM; Bourbigot, B; Cledes, J; Islam, MS; Le Pogamp, P; Leglise, D; Rivalan, J1
Patel, SB; Wu, J; Zhu, YH1
Di Paolo, S; Morrone, LF; Resta, F; Schena, A; Schena, FP; Stallone, G1
Gerbes, AL; Parhofer, KG; Schwandt, P; Zachoval, R1

Trials

1 trial(s) available for cyclosporine and Hyperlipoproteinemias

ArticleYear
Short-term effects of statin therapy in patients with hyperlipoproteinemia after liver transplantation: results of a randomized cross-over trial.
    Journal of hepatology, 2001, Volume: 35, Issue:1

    Topics: Aged; Cholesterol; Cholesterol, LDL; Cross-Over Studies; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Pravastatin; Prospective Studies; Pyridines; Time Factors

2001

Other Studies

4 other study(ies) available for cyclosporine and Hyperlipoproteinemias

ArticleYear
Insights into the effects of hyperlipoproteinemia on cyclosporine A biodistribution and relationship to renal function.
    The AAPS journal, 2006, Oct-27, Volume: 8, Issue:4

    Topics: Animals; Biological Availability; Cyclosporine; Hyperlipoproteinemias; Kidney; Kidney Function Tests; Male; Rats; Rats, Sprague-Dawley; Tissue Distribution

2006
Serum lipoprotein (a) in renal transplant recipients treated with cyclosporin monotherapy compared to conventional treatment.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1994, Volume: 9, Issue:3

    Topics: Adult; Azathioprine; Cyclosporine; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemias; Kidney Transplantation; Lipoprotein(a); Male; Middle Aged; Steroids

1994
Cyclosporin-induced dyslipoproteinemia is associated with selective activation of SREBP-2.
    The American journal of physiology, 1999, Volume: 277, Issue:6

    Topics: Acetyl-CoA Carboxylase; Animals; Apolipoprotein B-100; Apolipoprotein B-48; Apolipoproteins B; Cholesterol, VLDL; Coronary Disease; Cyclosporine; Cytochrome P-450 Enzyme System; DNA-Binding Proteins; Farnesyl-Diphosphate Farnesyltransferase; Fatty Acid Synthases; Fatty Acids; Female; Gene Expression Regulation, Enzymologic; Hydroxymethylglutaryl CoA Reductases; Hyperlipoproteinemias; Immunosuppressive Agents; Immunotherapy; Leucine Zippers; Lipase; Liver; Mice; Receptors, LDL; RNA, Messenger; Stearoyl-CoA Desaturase; Steroid Hydroxylases; Sterol Regulatory Element Binding Protein 2; Sterols; Transcription Factors; Transcription, Genetic; Triglycerides

1999
Are lipid-dependent indicators of cardiovascular risk affected by renal transplantation?
    Clinical transplantation, 2000, Volume: 14, Issue:2

    Topics: Adolescent; Adult; Age Factors; Apolipoprotein A-I; Apolipoproteins B; Arteriosclerosis; Body Mass Index; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Creatinine; Cyclosporine; Female; Humans; Hyperlipoproteinemias; Immunosuppressive Agents; Incidence; Kidney Transplantation; Linear Models; Lipoprotein(a); Lipoproteins; Male; Middle Aged; Risk Factors; Sex Factors; Triglycerides

2000